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Certain genetic syndromes can result in charac-
teristic cutaneous abnormalities, which may lead
directly to the diagnosis of the underlying disease.
Early diagnosis and treatment of these syndromes are
often important to improve treatment and the
patient’s development.
Kabuki syndrome (KS) is a pediatric congenital
disorder of genetic origin with complicated manifes-
tations, occurring in approximately 1 of 32,000
newborns.1 KS was first described in Japan in 1981
and is named after a Japanese dance drama.2 The
notable eyes characteristic for KS patients resembles
the makeup used in Kabuki theater, showing ever-
sion of the lateral lower eyelids and broad, arched
eyebrows with lateral sparseness.1
The 5 main typical manifestations of KS include
facial features, skeletal anomalies, dermatoglyphic
abnormalities, mild-to-moderate intellectual
disability, and postnatal growth deficiency.3 The
clinical features expressed vary widely between
individual patients. Beside the main manifestations,
other malformations are common, such as urogenital
and cardiac malformations.2
Following recent advances in epigenetics, is it
now known that KS is mainly caused by a dominant
de novo pathogenic mutation. In 52% to 76% of
patients, the mutation is located on the KMT2D gene
of chromosome 12 and is called KS type I. In the other
variant, the mutation is located on the KDM6A gene
on chromosome X, which is inherited in an X-linked
dominant pattern and is called KS type II.3
Both the KMT2D gene and the KDM6A gene
regulate histone expression. Mutations in these
genes result in abnormal histone functioning, result-
ing in impaired expression of certain other genes.Department of Dermatology, Amphia Medical Center,
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development, differentiation, metabolism, and tu-
mor suppression.4 The KDM6A gene plays a critical
role in developmental regulation.5 Unlike in KS type
I, developmental delay and learning disabilities are
generally moderate to severe in boys but mild to
moderate in girls with KS type II due because of the
X-linked inheritance pattern.6CASE PRESENTATION
We report a case of a 4-year-old white girl with
genetically proven KS type I, showing a mutation of
the KMT2D gene on chromosome 12. The patient
was a firstborn child, born at 37 weeks through
vacuum-assisted vaginal delivery. She had orofacial
cleft and mental retardation resulting in develop-
mental disabilities. Despite speech therapy, only
nonverbal communication was possible, as she
remained unable to produce words. She walked
since the age of 2. Her social skills were improving,
and she was playing with other kids. We observed no
difficulties with understanding and following
instructions.
She was referred to the dermatology outpatient
department with striking patchy capillary malforma-
tions (CM) (Figs 1 and 2) (para)medially on the (left)
upper back and bilaterally along the lumbosacralJAAD Case Reports 2019;5:560-2.
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Fig 1. Capillary malformations on the lower back in a
child with KS type I.
Fig 2. Capillary malformations on the lower back in a
child with KS type I (close up).
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birth, were slowly expanding in width, and remained
visibly unchanged to the patient’s parents with
regard to thickness and brightness. The malforma-
tions were asymptomatic; hence, no additional
dermatologic analysis or treatment was applied.
General physical examination found that the
patient had a small length (96 cm [-1.94 standard
deviation (SD)]) and normal weight (14,4 kg [-0.03
SD]), head circumference (49 cm [-0.63 SD]) and
body mass index (15,6 kg/m2 [0,18 SD]). Cardiac
ultrasonography and lumbar and thoracic spine
ultrasonography found no abnormalities.
Abdominal ultrasonography unveiled a urogenital
malformation, showing a duplicated ureter. No
additional magnetic resonance imaging scan was
made, which would be indicated to rule out other
dysgraphia defects associated with CM in the lumbo-
sacral region.DISCUSSION
Multiple malformations have been associated
with KS, but typically no CM are seen. CM are
localized abnormalities that occur during vascular
development. CMmay cause aesthetic problems and
can continue to grow throughout life. CM are
commonly called port wine stains and are the most
common cutaneous vascular malformations,
affecting 0.3% of newborns.7 Based on the abnormal
microanatomy seen in vascular malformations, the
underlying genes may have encoded structural pro-
teins of the endothelial or smooth muscle cells or
possibly extracellular matrix proteins.8 CM may
occur as solitary findings or may be associated with
other malformations as part of genetic syndromes.
Four syndromes are known to be characterized by
CM: Sturge-Weber syndrome, Klippel-Trenaunay
syndrome, Parkes-Weber syndrome (PWS), and
capillary malformationearteriovenous malformationsyndrome (CM-AVM). Uncovering the genetic basis
for Sturge-Weber syndrome, Klippel-Trenaunay syn-
drome, PWS, and CM-AVM has posed a challenge, as
these syndromes usually occur sporadically,
although some cases of autosomal-dominant inher-
itance of PWS and CM-AVM have been described.9
To our knowledge, CM have not yet been
associated with KS. The CM described in the pre-
sented case may be an incidental coexisting finding
apart from KS. This case might also point at a yet-
unknown link between KS and CM. Even though no
proof for a link was found in this case, a link would
be important in recognizing KS in an earlier stage,
leading to timelier medical and developmental pa-
tient support.
CONCLUSION
The authors report an atypical case of KS showing
CM in a child with genetically proven KS type I. To
our knowledge, these malformations have not yet
been associated with KS. The malformations may be
an incidental coexisting finding apart from KS or
point at a yet-unknown link with KS. A link would be
clinically important to help ensure timely diagnosis
of KS, enabling earlier medical and developmental
patient support.
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